Chronic inflammation contributes to colorectal carcinogenesis. To determine whether serum cytokines are associated with colon polyps, 126 asymptomatic men (48-65 years) were recruited during colonoscopy. Serum cytokine concentrations were measured. Odds ratios were determined using polytomous logistic regression for polyp number and type. Men with serum monocyte chemotactic protein-3 (MCP-3) or soluble interleukin-4 receptor (sIL-4R) concentrations in the highest tertile were 0.2 times less likely to have three or more polyps relative to no polyps. For each increase in serum MCP-3 or sIL-4R tertile a man was about 0.4 times less likely to have three or more polyps than to have no polyps. Men with serum concentrations of interferon-α2 (IFN-α2) or interleukin (IL)-7 in the highest tertile were three times more likely to have an adenoma than no polyps. Those with serum IL-8 concentrations in the highest tertile were four times more likely to have an adenoma than no polyps. For each increase in serum IFN-α2, IL-7, or IL-8 tertile an individual was 1.8 times more likely to have an adenoma than to have no polyps. Serum concentrations of MCP-3, sIL-4R, IFN-α2, IL-7, and IL-8 may indicate which men are more likely to have colorectal polyps.
Introduction
Colonoscopy is known to be highly effective at preventing cases of colorectal cancer (Zauber et al., 2012) . However, many individuals are reluctant to be screened in this manner (McLachlan et al., 2012) , and the procedure is costly (Rosenthal, 2013; Sinsky and Dugdale, 2013) . Methods to identify which individuals would benefit most from colonoscopy are needed. One such method may be the use of serum factors to predict individuals at highest risk for the presence of colorectal polyps.
Inflammation is a critical component of cancer initiation and progression (Hanahan and Weinberg, 2011) . Initial chronic inflammation can activate cellular functions that induce irreversible DNA damage and increase the risk of cancer . However, the immune system also responds to already mutated cells, and chronic inflammation may result from an inability of the immune system to kill and clear those cells. Typically, it is the local epithelial cells or innate immune cells such as neutrophils, monocytes/macrophages, and dendritic cells that are responsible for these actions. These cell types synthesize cytokines such as monocyte chemotactic protein (MCP)-3, macrophage-derived chemokine (MDC), interferon-α2 (IFN-α2), interleukin(IL)-7, and IL-8. When these proteins are produced in high quantities locally, they can diffuse from the tissue and be detected in the blood.
Because inflammation is commonly linked to cancer initiation as well as progression (Elinav et al., 2013) , serum cytokines levels are likely to be useful predictive biomarkers of colorectal polyp formation and risk of future colorectal cancer. In fact, a recent study successfully identified a prognostic classifier for colorectal metastasis using serum concentrations of 17 cytokines (Chen et al., 2014) . Another study demonstrated that colorectal dysplasia was positively associated with local intestinal inflammation and inversely associated with immune therapy (Rubin et al., 2013) . However, few studies have attempted to identify serum cytokines associated with colorectal polyps. This study investigated potential associations between serum cytokine levels and colorectal polyp number or type in a population of adult men undergoing preventative screening colonoscopy.
Materials and methods

Study population
Between August 2009 and February 2011, healthy males ranging from 48 to 65 years of age were recruited from MSUaffiliated clinics, either the Tri-County Gastroenterology Clinic (Macomb, Michigan, USA) or Michigan State University Clinic (East Lansing, Michigan, USA), at the time of colonoscopy. These individuals were undergoing routine colonoscopies and were asymptomatic. Exclusion criteria included: (i) cancer within the past 2 years, (ii) surgery within the past 2 years, (iii) inflammatory bowel diseases (i.e. Crohn's, ulcerative colitis), (iv) autoimmune disorders (i.e. rheumatoid arthritis, HIV/AIDS, lupus), (v) type I or type II diabetes, (vi) chronic liver or kidney disease, (vii) history of heart failure, (viii) current immunosuppressant usage (i.e. prednisone), (ix) asthma, chronic obstructive pulmonary disease, or other lung problems, (x) familial adenomatous polyposis, and (xi) Lynch syndrome or hereditary nonpolyposis colorectal cancer. A total of 126 men (>96% White) participated in the study (Table 1) . At the time of enrollment, immediately before routine colonoscopy, written informed consent was obtained and clinical metadata on subject comorbidities, current medications, and family history were collected. Anthropometric measures were taken to calculate BMI and to record waist circumference (Comstock et al., 2014a) . In addition, at the time of enrollment, venous blood was drawn and serum was isolated by standard procedures and stored at − 80°C. The study was approved by the institutional review board of Michigan State University (IRB# 08-786).
Colonoscopy interpretation
A full colonoscopy was performed on each participant. A gastroenterologist (MSU-affiliated clinics, Michigan, USA) categorized the location of each polyp during the colonoscopy. Board-certified pathologists assigned a polyp type to each specimen collected during colonoscopy (regional medical center pathology departments).
Serum biomarker analysis
Serum concentrations (Table 2 ) of the soluble interleukin-4 receptor (sIL-4R), soluble CD30 (sCD30), soluble glycoprotein (gp) 130 (sgp130), and the soluble interleukin-2 receptor (sIL-2Rα) were determined using a multiplex kit for soluble cytokine receptors (HSCR-32K; Millipore, Billerica, Massachusetts, USA) as per the manufacturer's instructions. Further, serum concentrations of IFN-α2, IL-7, IL-8, MCP-3, eotaxin, fms-like tyrosine kinase-3 ligand (FLT-3L), fractalkine, granulocyte-colony stimulating factor (G-CSF), granulocyte macrophage-colony stimulating factor (GM-CSF), GRO1 oncogene (CXCL1/ GRO), interferon-γ (IFN-γ), IL-15, transforming growth factor-α (TGF-α), IL-3, IL-4, IL-5, IL-9, IL-13, and MDC were measured using a multiplex human cytokine/chemokine kit (MPXHCYTO-60K; Millipore). Multiplex assays were analyzed on a Bio-Plex 100 using Bio-Plex 4.1 software (Bio-Rad, Hercules, California, USA).
Statistical analyses
Frequencies, means, SDs, and ranges were calculated for descriptive analysis.
Because the serum cytokine concentrations were nonnormally distributed, Spearman's correlations are presented (Table 3 ). All of the cytokines and soluble receptors were categorized into tertiles for polytomous logistic regression analysis. Biological cutoff points were used for the outcome variables: polyp number and polyp type. Polyp number was set to four categories: 0, 1, 2, or ≥ 3 polyps. Polyp type was set to three categories: no polyps, hyperplastic polyp(s), or tubular adenoma(s). For polyp type, each individual was assigned a single score based on the colorectal polyp with the worst pathology.
Each individual was assigned a smoking status of 'never smoked' or 'ever smoked'. An individual was classified as 'never smoked' if he had smoked fewer than 100 cigarettes over the course of his lifetime. Smoking status was missing for 22 individuals (17.5% missingness). All missing data were considered missing at random.
Multiple imputation (seed = 20 121 119, imputations = 7) was used to impute all missing smoking data and the one participant's value missing for the factors measured with the multiplex human cytokine/chemokine kit (Yuan, 2011) . The factors age, smoking, polyp type, polyp number, and the factor being imputed were used in the imputation algorithm of missing values (Moons et al., 2006) .
Odds ratios (ORs) were determined using polytomous logistic regression models for categorical outcome data with more than two levels. A generalized logit model (also known as a 'baseline category logit model') formed the basis of the polytomous logistic regression model for our analyses. In this model, men having three or more polyps, two polyps, or one polyp were compared with men having no polyps. Results were obtained for each serum factor categorized into tertiles (with the lowest tertile as reference) for each category of polyp number or polyp type relative to no polyp. For clarity, only results from the categories featuring the most polyps (≥3) and the polyp type most likely to progress to colorectal cancer (adenoma) are presented. For dichotomous outcomes, odds ratios were determined using logistic regression. All models were adjusted for age and smoking status. A test for trend was carried out across tertiles for the factors of interest. Because imputation was used, multiple imputation analysis (Proc MIANALYZE) was used to determine the results from the analysis of the imputed data sets. SAS version 9.3 (SAS Institute Inc., Cary, North Carolina, USA) was used for all statistical analysis. P of up to 0.05 indicates significance. Reported as mean (range).
Results
Some details of this study population have recently been published (Comstock et al., 2014a (Comstock et al., , 2014b (Comstock et al., , 2014c . Briefly (Table 1) , 57 (45%) of the 126 participants had at least one polyp. The remaining participants had no polyps. Of the participants, 37 (29.4%) had a tubular adenoma. Furthermore, 17 of the 23 (18%) participants with three or more polyps had at least one tubular adenoma.
No associations between polyp number or polyp type were found for the following factors: eotaxin, FLT-3L, fractalkine, G-CSF, GM-CSF, GRO, IFN-γ, IL-15, TGF-α, sCD30, sgp130, sIL-2Rα, IL-3, IL-4, IL-5, IL-9, and IL-13. Only serum concentrations of MDC were associated with the presence of hyperplastic polyps. There were no individual effects among MDC tertiles, but there was a 2.2 fold increase in the odds (95% confidence interval 1.1-4.4) of having a hyperplastic polyp compared with having no polyp for each increase in the tertile of MDC serum concentration (P = 0.0227).
Concentrations of cytokines and soluble receptors that are significantly associated with either polyp number or type are presented in Table 2 . These serum factors were correlated with each other as well as with participant characteristics (Table 3) . Only one factor was significantly correlated with age: sIL-4R was inversely correlated with age. Multiple cytokines including IFN-α2, IL-7, IL-8, IL-10, and MDC were positively correlated with BMI. All of these serum cytokines, except IL-10, were also positively correlated with waist circumference. Neither BMI nor waist circumference was correlated with serum sIL-4R concentration. With a few exceptions, serum cytokine levels were positively correlated with each other. Notably, serum MDC concentration was not correlated with serum IL-10 or MCP-3 concentration and tended to be negatively correlated with serum sIL-4R concentration. Neither IFN-α2 nor IL-8 was correlated with sIL-4R serum concentration.
High serum concentrations of MCP-3 and sIL-4R reduced the odds of a participant having three or more polyps. Compared with men with a serum MCP-3 concentration of up to 7.16 pg/ml, men with a serum MCP-3 concentration greater than 15.98 pg/ml were 0.21 times less likely to have three or more polyps (P = 0.0196) relative to no polyps (Fig. 1a) . In addition, for each increase in the serum MCP-3 tertile, a man was 0.44 times less likely to have three or more polyps than to Serum cytokines and colorectal polyps Comstock et al. 175 have no polyps (P = 0.0126). When compared with men with a serum sIL-4R concentration of up to 1360.0 pg/ml, men with a serum sIL-4R concentration greater than 1575.0 pg/ml were 0.22 times less likely to have three or more polyps (P = 0.0246) relative to no polyps (Fig. 1b) . For each increase in the serum sIL-4R tertile, a man was 0.45 times less likely to have three or more polyps than to have no polyps (P = 0.0180). Conversely, high serum levels of MDC tended to increase the odds of a participant having three or more polyps compared with no polyps (Table 4) . Serum concentrations of IFN-α2, IL-7, IL-8, and IL-10 were not associated with polyp number.
Concentrations of several serum cytokines were associated with the presence of a colorectal adenoma (Table 5 ). Men with a serum IFN-α2 concentration greater than 33.12 pg/ml were 2.8 times more likely than men with a serum IFN-α2 concentration of up to 14.98 pg/ml to have an adenoma (P = 0.0468) relative to no polyps (Fig. 2a) . As the tertile of serum IFN-α2 increased, an individual was 1.75 times more likely to have an adenoma than to have no polyp (P = 0.0391).
When compared with men with a serum IL-7 concentration of up to 3.54 pg/ml, men with a serum IL-7 concentration greater than 12.06 pg/ml were 3.3 times more likely to have an adenoma (P = 0.0277) than no polyps (Fig. 2b) . As the serum IL-7 tertile increased, an individual was 1.82 times more likely to have an adenoma than to have no polyps (P = 0.0288). Compared with men with a serum IL-8 concentration of up to 6.76 pg/ml, men with a serum IL-8 concentration greater than 10.74 pg/ml were 4.0 times more likely to have an adenoma (P = 0.0158) relative to no polyps (Fig. 2c) . Further, for each increase in serum IL-8 tertile, an individual was 1.85 times more likely to have an adenoma than to have no polyp (P = 0.0213). A high serum concentration of IL-10 tended to be positively associated with the presence of an adenoma (Table 5) . However, high serum concentrations of sIL-4R tended to be negatively associated with the presence of an adenoma. The serum concentrations of MCP-3 and MDC were not associated with the presence of an adenoma.
Discussion
Recent studies have evaluated the relationship between serum cytokines and colorectal cancer, yet few have comprehensively analyzed the relationship between serum cytokine concentrations and colorectal polyps (Bunger et al., 2012; Kang et al., 2013) . In this study, serum concentrations of the cytokines MCP-3, sIL-4R, IFN-α2, IL-7, and IL-8 were found to be associated with polyp number or type in asymptomatic adult male individuals. Specifically, high levels of MCP-3 or sIL-4R were associated with a decreased odds of having three or more polyps, whereas high levels of IFN-α2, IL-7, and IL-8 were associated with an increased odds of having a colorectal adenoma. Many other serum cytokines, including eotaxin, G-CSF, GM-CSF, GRO1, IFN-γ, and IL-5, were not associated with either polyp number or the presence of a colorectal adenoma.
Most studies of colorectal polyps focus on select markers of inflammation, most commonly IL-6, tumor necrosis factor-α (TNF-α), and C-reactive protein (CRP; Il'yasova et al., 2005; Kim et al., 2008; Wild et al., 2010; Hopkins et al., 2012) . These studies found IL-6, TNF-α, and CRP, as well as noncytokine markers, such as carcinoembryonic antigen and ferritin, to be positively associated with the presence of colorectal adenomas as well as with general cancer incidence. As we have previously published, although IL-6 was not associated, TNF-α was significantly associated with the presence of colorectal adenomas in our study population (Comstock et al., 2014a) . We did not measure CRP concentrations. Notably, some of the serum expression patterns identified herein are consistent with findings from studies on colorectal polyps and colorectal carcinomas. In studies evaluating large sets of cytokines, TNF-α and IL-8 were found to be associated with polyps (Bunger et al., 2012; Kang et al., 2013) . We also identified associations of TNF-α (Comstock et al., 2014a) and IL-8 with polyps. In a report by Chen et al. (2014) , IFN-α2, IL-10, MCP-3, MDC, IL-7, IL-8, TNF-α, IFN-γ-induced protein (IP)-10, and vascular endothelial growth factor (VEGF) were found to be associated with metastatic colorectal cancer. IL-8, IP-10, and TNF-α were also found to be positively associated with the presence of colorectal carcinoma in a separate population (Choi et al., 2013) . Our study identified associations of IFN-α2, IL-10, MCP-3, MDC, IL-7, and IL-8 with colorectal polyps. In addition, TNF-α, IP-10, and VEGF have been previously reported to be associated with colorectal polyps in this population (Comstock et al., 2014a (Comstock et al., , 2014c . Therefore, data from the current study population support those from other studies analyzing serum cytokines in cases of colorectal neoplasia. Furthermore, this study expands previous knowledge by demonstrating that these serum cytokine levels are modified even in the early stages of colon cancer.
Cytokines are important for cancer progression. They affect apoptosis, proliferation, angiogenesis, and mutagenesis. Most frequently, these functions are accomplished by signaling through molecules such as nuclear factor-kappa B, cyclooxygenase-2, and signal tranducer and activator of transcription 3 (STAT3; Parsons et al., 2005; Dreesen and Brivanlou, 2007; . For instance, STAT3 activation is pivotal in tumorigenesis (reviewed by Coussens et al., 2013 and Fan et al., 2013) . Several of the cytokines that are positively associated with increased numbers of polyps or the presence of an adenoma, including IFN-α2 (Raz et al., 1994) , IL-7 (Qin et al., 2001) , and IL-10 (Finbloom and Winestock, 1995) , signal through STAT3. In addition, IL-4 signals through STAT3 (Rolling et al., 1996) , and herein the soluble IL-4R was found to be inversely associated with having three or more polyps as well as with the presence of a tubular adenoma, indicating that STAT3 signaling may be inhibited under conditions of high sIL-4R. Serum leptin, which also activates STAT3 (Bjorbaek et al., 1997) , was previously found to be positively associated with an increased odds of having three or more polyps, as well as with increased odds of having a tubular adenoma (Comstock et al., 2014a) .
Serum levels of IL-8, an angiogenic protein that is also known as CXCL8, were positively associated with the odds of having an adenoma compared with no polyp. Macrophages, endothelial cells, and tumors produce IL-8, drawing granulocytes and activating neutrophils to the local environment. IL-8 induces VEGF expression, leading to angiogenesis (Singh et al., 2010; Kotyza, 2012; TodorovicRakovic and Milovanovic, 2013) . This chemokine also stimulates tumor cell invasiveness and cancer progression (Waugh and Wilson, 2008; Fernando et al., 2011; Palena et al., 2012; Todorovic-Rakovic and Milovanovic, 2013) . In a study of colorectal tissue, IL-8 mRNA and protein were found to be more highly expressed in samples from colorectal tumors compared with those obtained from areas of inflammatory colorectal conditions or adenomas of the colon/rectum (Rubie et al., 2007) . In combination with the fact that serum IL-8 The odds ratio (OR) of having three or more polyps relative to no polyps is negatively associated with serum (a) MCP-3 and (b) sIL-4R levels. (a) Compared with men with a serum MCP-3 concentration of up to 7.16 pg/ml, men with a serum MCP-3 concentration greater than 15.98 pg/ml are 0.21 times less likely to have three or more polyps (P = 0.0196) relative to no polyps. In addition, for each increase in the serum MCP-3 tertile, a man is 0.44 times less likely to have three or more polyps than have no polyps (P = 0.0126). Reference group = men with MCP-3 concentrations in the lowest tertile. (b) Compared with men with a serum sIL-4R concentration of up to 1360.0 pg/ml, men with a serum sIL-4R concentration greater than 1575.0 pg/ml are 0.22 times less likely to have three or more 3 polyps (P = 0.0246) relative to no polyps. In addition, for each increase in the serum sIL-4R tertile, a man is 0.45 times less likely to have three or more polyps than have no polyps (P = 0.0180). Reference group = men with sIL-4R concentrations in the lowest tertile. The models were adjusted for age and smoking status (ever/never). CI, confidence interval; MCP-3, monocyte chemotactic protein-3; sIL-4R, soluble interleukin-4 receptor. Model is adjusted for age and ever/never smoking. Bold indicates P<0.05. CI, confidence interval; IFN-α2, interferon-α2; IL, interleukin; MCP-3, monocyte chemotactic protein-3; MDC, macrophage-derived chemokine; sIL-4R, soluble interleukin-4 receptor.
levels are associated with colorectal carcinoma and polyps, these results suggest that increased IL-8 levels, both locally and systemically, are important in the development of colorectal polyps, as well as colorectal cancer.
Inflammatory cytokines also activate proliferative responses during cancer initiation steps. In this study, the levels of IL-7 were found to be positively associated with the presence of an adenoma. This is potentially related to the ability of this cytokine to promote proliferation of a variety of cell types (Namen et al., 1988; Vollger and Uittenbogaart, 1993) . It may do this through STAT signaling ( Van der Plas et al., 1996) , as well as through the activation of phosphoinositide-3-kinase (Dadi and Roifman, 1993) . Furthermore, IL-7 can stimulate the production of other inflammatory cytokines (Appasamy, 1993) .
The immune system can inhibit as well as enhance the tumorigenicity of precancerous or cancerous cells (Chow et al., 2012) . Two serum proteins, MCP-3 and sIL-4R, that were found to be inversely associated with colorectal polyps in the present analysis likely contribute cytotoxic skewing effects. MCP-3, also known as chemokine (C-C motif) ligand (CCL)7, recruits and activates most types of immune cell, including natural killer cells (Alam et al., 1994; Allavena et al., 1994; Noso et al., 1994; Sozzani et al., 1994; Taub et al., 1995; Uguccioni et al., 1995; Xu et al., 1995; Loetscher et al., 1996) . In fact, MCP-3 stimulates tumor regression (Fioretti et al., 1998; Wetzel et al., 2001) , and herein high serum MCP-3 levels were found to be associated with a decreased odds of having three or more polyps compared with having no polyps, demonstrating that MCP-3 can be protective at high serum concentrations. In addition, the sIL-4R level was negatively associated with the odds of having three or more polyps compared with no polyps and tended to be negatively associated with the odds of having an adenoma compared with no polyps. These associations are likely due to the inhibitory effect of this soluble cytokine receptor on IL-4 signaling. Through inhibition of IL-4, sIL-4R creates an environment that is more conducive to polyp/tumor regression. Anti-IL-4 therapeutic antibodies have been demonstrated to reprogram tumor-associated macrophages, monocytes, and other cells toward cytotoxic phenotypes in mammary cancer (DeNardo et al., 2009) . Thus, the inverse relationship between serum MCP-3 and sIL-4R and colorectal polyp number could potentially be due to their cytotoxic skewing effects.
Cytokines, such as IL-10, which are typically regulatory (O'Garra and Vieira, 2007) , are elevated in cancer (Sato et al., 1996; Mustea et al., 2006) . Some IL-10 polymorphisms are associated with cancer (Howell and Rose-Zerilli, 2006 ). In the current study population, serum IL-10 levels tended to be positively associated with having an adenoma compared with no polyp. MDC, also known as CCL22, is associated with tumor promotion because it attracts regulatory T cells to the tumor site (Faget et al., 2011) . The presence of these regulatory T cells leads to the inhibition of other immune cells, specifically cytotoxic immune cells. The positive relationship trends between IL-10 and polyp type and between MDC and polyp number could potentially be due to their anticytotoxic skewing effects.
The time during polyp formation and progression determines disease trajectory. Inflammation and the immune system are important throughout tumor development, from initiation to metastasis, but many of the specifics are unknown (Coussens et al., 2013; Fan et al., 2013) . The association of specific serum cytokine concentrations with the presence of colorectal polyps supports the hypothesis that serum cytokines likely play a role in colorectal cancer initiation and progression. However, our results do not address the effects of changes in serum cytokine levels on progression because we only analyzed one point in time for each participant and did not analyze the associations of cytokine combinations with polyp number or the presence of adenoma. Different cytokines were found to be inversely associated with polyp number (MCP-3, sIL-4R) than were positively associated with the presence of an adenoma (IFN-α2, IL-7, IL-8), suggesting that initiation may rely on a cytotoxic or damaging environment, whereas progression may rely on factors that promote angiogenesis and proliferation. concentration of up to 14.98 pg/ml, men with a serum IFN-α2 concentration greater than 33.12 pg/ml are 2.8 times more likely to have an adenoma (P = 0.0468) relative to no polyps. Further, for each increase in serum IFN-α2 tertile, an individual is 1.75 times more likely to have an adenoma than to have no polyps (P = 0.0391). Reference group = men with IFN-α2 concentrations in the lowest tertile. (b) Compared with men with a serum IL-7 concentration of up to 3.54 pg/ml, men with a serum IL-7 concentration greater than 12.06 pg/ml are 3.3 times more likely to have an adenoma (P = 0.0277) relative to no polyps. Further, for each increase in the serum IL-7 tertile, an individual is 1.82 times more likely to have an adenoma than to have no polyps (P = 0.0288). Reference group = men with IL-7 concentrations in the lowest tertile. (c) Compared with men with a serum IL-8 concentration of up to 6.76 pg/ml, men with a serum IL-8 concentration greater than 10.74 pg/ml are 4.0 times more likely to have an adenoma (P = 0.0158) relative to no polyps. Further, for each increase in the serum IL-8 tertile, an individual is 1.85 times more likely to have an adenoma than to have no polyps (P =0.0213). Reference group = men with IL-8 concentrations in the lowest tertile. All models were adjusted for age and smoking status (ever/never). CI, confidence interval; IFN-α2, interferon-α2; IL, interleukin.
Serum cytokines and colorectal polyps Comstock et al. 179 Strengths of the present study include its design. This study was cross-sectional with consecutive enrollment, resulting in reduced enrollment bias. In addition, only asymptomatic individuals undergoing a complete screening were enrolled, and individuals immediately participated in the study, eliminating potential bias due to loss to follow-up. We selected healthy individuals lacking conditions known to be related to underlying inflammation to avoid detection of unrelated inflammatory signals. Trained staff measured body weight and height; hence, there was no reliance on self-report. The information collected from the participants on relevant confounding variables enabled factors such as smoking history to be controlled for in the analysis. Therefore, the results of this study are likely typical of men of an ethnicity and age similar to those in this well-defined study population.
However, caution must be used when interpreting the results of this study because the study has some limitations. For instance, the results may not apply to individuals of other ethnicities or to women, as this study was conducted in a sample of primarily white, adult male individuals. Some data were imputed. However, these few imputations likely have minimal effects on the overall results. The associations described in this study were based on cross-sectional data, thus cause cannot be assigned to any factor identified as associated with polyp number or type. Only a single timepoint is analyzed, but the effects of cytokines on polyp formation may be related to the duration and localization of exposure. Local production is difficult to measure, and serum measurements are more useful in a clinical setting. Furthermore, although we did not detect associations between a number of cytokines and polyp number or the presence of an adenoma, this could be due to the sample size or specific characteristics of the population rather than the result of a lack of association under all circumstances. In summary, the results of this study should be verified using larger, more representative samples.
Further examination of the serum factors identified in this study as they relate to polyp formation and progression could elucidate the pathways by which the immune system successfully prevents cancer or, alternatively, contributes to cancer. In addition, although the identified factors may also be elevated in the serum of individuals with other tumor types, the association of specific serum cytokine concentrations with the presence of colorectal polyps suggests that these serum factors could potentially predict which individuals are likely to have polyps and therefore would benefit from colonoscopy screening.
